Skip Navigation

Nucleic Acids Research 2005 33(7):2310-2317; doi:10.1093/nar/gki526
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (4674K) Freely available
Right arrow Screen PDF (467K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Gadelle, D.
Right arrow Articles by Forterre, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gadelle, D.
Right arrow Articles by Forterre, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 22 April 2005

© The Author 2005. Published by Oxford University Press. All rights reserved
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions{at}oupjournals.org

Article

Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol

D. Gadelle, C. Bocs, M. Graille1 and P. Forterre2,*

Institut de Genetique et Microbiologie, UMR CNRS 8621 Batiment 409, 91405 Orsay, France 1Institut de Biochimie et de Biophysique Moleculaire et Cellulaire, CNRS-UMR 8619, Universite Paris-Sud 91405 Orsay, France 2Institut Pasteur 25 rue du Docteur Roux, 75015 Paris, France

*To whom correspondence should be addressed. Tel: +33 1 45 68 87 91; Fax: +33 1 45 68 88 34; Email: forterre{at}pasteur.fr

Received January 11, 2005. Revised April 4, 2005. Accepted April 4, 2005.

Type II DNA topoisomerases have been classified into two families, Topo IIA and Topo IIB, based on structural and mechanistic dissimilarities. Topo IIA is the target of many important antibiotics and antitumoural drugs, most of them being inactive on Topo IIB. The effects and mode of action of Topo IIA inhibitors in vitro and in vivo have been extensively studied for the last twenty-five years. In contrast, studies of Topo IIB inhibitors were lacking. To document this field, we have studied two Hsp90 inhibitors (radicicol and geldanamycin), known to interact with the ATP-binding site of Hsp90 (the Bergerat fold), which is also present in Topo IIB. Here, we report that radicicol inhibits the decatenation and relaxation activities of Sulfolobus shibatae DNA topoisomerase VI (a Topo IIB) while geldanamycin does not. In addition, radicicol has no effect on the Topo IIA Escherichia coli DNA gyrase. In agreement with their different effects on DNA topoisomerase VI, we found that radicicol can theoretically fit in the ATP-binding pocket of the DNA topoisomerase VI ‘Bergerat fold’, whereas geldanamycin cannot. Radicicol inhibited growths of Sulfolobus acidocaldarius (a crenarchaeon) and of Haloferax volcanii (a euryarchaeon) at the same doses that inhibited DNA topoisomerase VI in vitro. In contrast, the bacteria E.coli was resistant to this drug. Radicicol thus appears to be a very promising compound to study the mechanism of Topo IIB in vitro, as well as the biological roles of these enzymes in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
G. Fu, J. Wu, W. Liu, D. Zhu, Y. Hu, J. Deng, X.-E. Zhang, L. Bi, and D.-C. Wang
Crystal structure of DNA gyrase B' domain sheds lights on the mechanism for T-segment navigation
Nucleic Acids Res., September 1, 2009; 37(17): 5908 - 5916.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A.-C. Lindas, E. A. Karlsson, M. T. Lindgren, T. J. G. Ettema, and R. Bernander
A unique cell division machinery in the Archaea
PNAS, December 2, 2008; 105(48): 18942 - 18946.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
O. A. Toogun, D. C. DeZwaan, and B. C. Freeman
The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities
Mol. Cell. Biol., January 1, 2008; 28(1): 457 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Lundgren and R. Bernander
Genome-wide transcription map of an archaeal cell cycle
PNAS, February 20, 2007; 104(8): 2939 - 2944.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. D. Corbett and J. M. Berger
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol
Nucleic Acids Res., September 10, 2006; 34(15): 4269 - 4277.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.